HOME > 研究 > 詳細

2024/07/01

Personalized cancer treatment using patient-derived xenografts in zebrafish　(田中　利男)

Personalized cancer treatment using patient-derived xenografts in zebrafish is a rapidly developing area of research with the potential to revolutionize cancer care. Here's a breakdown of the process and its key aspects:

The Process:

Tumor Sample Collection: A small sample of a patient's tumor is extracted through a biopsy or surgery.

Zebrafish Embryo Preparation: Zebrafish embryos are bred and raised in controlled laboratory settings.

Tumor Transplantation: Tiny pieces of the patient's tumor are implanted into a specific location within the zebrafish embryo, often the yolk sac.

Drug Testing: Different potential cancer drugs are administered to the zebrafish containing the patient's tumor cells.

Tumor Monitoring: Researchers closely observe the growth and response of the tumors in the zebrafish embryos over time.

Drug Response Evaluation: Based on the tumor growth patterns, scientists can identify the most effective drugs for the patient's specific cancer.

Advantages:

Personalized Medicine: Drugs are selected based on the patient's tumor's unique response, potentially leading to more effective treatment.
Rapid Assessment: Zebrafish embryos develop quickly, allowing for faster evaluation of drug efficacy compared to traditional methods.
Cost-Effectiveness: Using zebrafish embryos is a relatively inexpensive way to test potential drugs.
Ethical Considerations: Zebrafish are invertebrates and likely don't experience pain, addressing ethical concerns present with some animal models.
Limitations:

Species Differences: While zebrafish share genetic similarities with humans, there might be discrepancies in drug metabolism and tumor behavior.
Tumor Complexity: Zebrafish embryos might not fully represent the intricate nature of human tumors, especially advanced or metastatic cancers.
Clinical Translation: Further research is needed to confirm the findings from zebrafish studies and translate them into successful clinical treatment strategies.
Overall, this approach holds promise for:

Developing individualized treatment plans: Tailoring treatment based on a patient's specific cancer can potentially improve outcomes.
Identifying new and more effective cancer drugs: Faster drug testing allows for quicker development of new treatment options.